Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Heart Surgery | Research article

Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018

Authors: Catarina Sousa, Paulo Nogueira, Fausto J. Pinto

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Nationwide hospital admissions data series have contributed to a reliable assessment of the changing epidemiology of infective endocarditis, even though conclusions are not uniform. We sought to use a recent populational series to describe the temporal trends on the incidence of infective endocarditis, its clinical characteristics and outcome results, in Portugal.

Methods

A nationwide retrospective temporal trend study on the incidence and clinical characterization of patients hospitalized with infective endocarditis, between 2010 and 2018.

Results

7574 patients were hospitalized with infective endocarditis from 2010 to 2018 in Portuguese public hospitals. The average length of hospitalization was 29.3 ± 28.7 days, predominantly men (56.9%), and 47.1% had between 60 and 79 years old. The most frequent infectious agents involved were Staphylococcus (16.4%) and Streptococcus (13.6%). During hospitalization, 12.4% of patients underwent heart valve surgery and 20% of the total cohort died. After a 1-year post-discharge follow-up, 13.2% of the total initial cohort had had heart valve surgery and 21.2% in total died. The annual incidence of infective endocarditis was 8.31 per 100,000 habitants, being higher in men (9.96 per 100,000 in males versus 6.82 in females, p < 0.001) and increased with age, peaking at patients 80 years old or older (40.62 per 100,000). In-hospital mortality rate significantly increased during the analyzed period, the strongest independent predictors being ischemic or hemorrhagic stroke, sepsis, and acute renal failure. Younger age and cardiac surgery had a protective effect towards a fatal outcome.

Conclusions

In Portugal, between 2010 and 2018, the incidence of infective endocarditis presented a general growth trend with a deceleration in the most recent years. Also, a significant rate of in-hospital complications, a mildly lower than expected stable surgical rate and a still high and growing mortality rate were noted.
Appendix
Available only for authorised users
Literature
2.
go back to reference Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE. 2013;8(12):1–17.CrossRef Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE. 2013;8(12):1–17.CrossRef
4.
go back to reference Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325–44.CrossRef Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325–44.CrossRef
6.
go back to reference Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRef Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRef
8.
go back to reference Marques A, Cruz I, Caldeira D, Alegria S, Gomes AC, Broa AL, et al. Risk factors for in-hospital mortality in infective endocarditis. Arq Bras Cardiol. 2020;114(1):1–8.PubMedPubMedCentral Marques A, Cruz I, Caldeira D, Alegria S, Gomes AC, Broa AL, et al. Risk factors for in-hospital mortality in infective endocarditis. Arq Bras Cardiol. 2020;114(1):1–8.PubMedPubMedCentral
11.
go back to reference Ilhão Moreira R, Coutinho Cruz M, Moura Branco L, Galrinho A, Coutinho Miranda L, Fragata J, et al. Infective endocarditis: surgical management and prognostic predictors. Rev Port Cardiol. 2018;37(5):387–94.CrossRef Ilhão Moreira R, Coutinho Cruz M, Moura Branco L, Galrinho A, Coutinho Miranda L, Fragata J, et al. Infective endocarditis: surgical management and prognostic predictors. Rev Port Cardiol. 2018;37(5):387–94.CrossRef
12.
go back to reference Melo L, Duarte J, Roque D, Oliveira I, Faustino A, Caetano J, et al. Endocardite Infecciosa: Casuística do Departamento de Medicina Interna de um Hospital - Resumo. Med Interna (Bucur). 2017;24(1):19–23. Melo L, Duarte J, Roque D, Oliveira I, Faustino A, Caetano J, et al. Endocardite Infecciosa: Casuística do Departamento de Medicina Interna de um Hospital - Resumo. Med Interna (Bucur). 2017;24(1):19–23.
13.
go back to reference Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369–413. https://doi.org/10.1093/eurheartj/ehp285.CrossRefPubMed Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369–413. https://​doi.​org/​10.​1093/​eurheartj/​ehp285.CrossRefPubMed
15.
go back to reference Fonager K, Lindberg J, Thulstrup AM, Pedersen L, Schønheyder HC, Sørensen HT. Incidence and short-term prognosis of infective endocarditis in Denmark, 1980–1997. Scand J Infect Dis. 2003;35(1):27–30.CrossRef Fonager K, Lindberg J, Thulstrup AM, Pedersen L, Schønheyder HC, Sørensen HT. Incidence and short-term prognosis of infective endocarditis in Denmark, 1980–1997. Scand J Infect Dis. 2003;35(1):27–30.CrossRef
16.
go back to reference Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HMK, Mirzoyev Z, et al. Temporal trends in infective endocarditis. J Am Med Assoc. 2005;293(24):3022.CrossRef Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HMK, Mirzoyev Z, et al. Temporal trends in infective endocarditis. J Am Med Assoc. 2005;293(24):3022.CrossRef
17.
go back to reference Sy RW, Kritharides L, Raymond W, Sy KL. Healthcare exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7.CrossRef Sy RW, Kritharides L, Raymond W, Sy KL. Healthcare exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7.CrossRef
18.
go back to reference Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11(1:48):1–7. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11(1:48):1–7.
19.
go back to reference Selton-Suty C, Celard M, Le MV, Doco-lecompte T, Chirouze C, Selton-suty C, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRef Selton-Suty C, Celard M, Le MV, Doco-lecompte T, Chirouze C, Selton-suty C, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.CrossRef
21.
go back to reference Pant S, Patel NNJ, Patel NNJ, Badheka A, Mehta JL, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6.CrossRef Pant S, Patel NNJ, Patel NNJ, Badheka A, Mehta JL, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6.CrossRef
24.
go back to reference Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. J Am Med Assoc. 2017;317(16):1652–60.CrossRef Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. J Am Med Assoc. 2017;317(16):1652–60.CrossRef
25.
go back to reference Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7(1):27–35.CrossRef Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7(1):27–35.CrossRef
26.
go back to reference Olmos C, Vilacosta I, Fernández-Pérez C, Bernal JL, Ferrera C, García-Arribas D, et al. The evolving nature of infective endocarditis in Spain. J Am Coll Cardiol. 2017;70(22):2795–804.CrossRef Olmos C, Vilacosta I, Fernández-Pérez C, Bernal JL, Ferrera C, García-Arribas D, et al. The evolving nature of infective endocarditis in Spain. J Am Coll Cardiol. 2017;70(22):2795–804.CrossRef
27.
go back to reference Shah ASV, McAllister DA, Gallacher P, Astengo F, Pérez JAR, Hall J, et al. Incidence, microbiology and outcomes in patient hospitalized with infective endocarditis. Circulation. 2020;141:2067–77. CrossRef Shah ASV, McAllister DA, Gallacher P, Astengo F, Pérez JAR, Hall J, et al. Incidence, microbiology and outcomes in patient hospitalized with infective endocarditis. Circulation. 2020;141:2067–77. CrossRef
33.
go back to reference Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.CrossRef Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.CrossRef
34.
go back to reference Head SJ, Mostafa Mokhles M, Osnabrugge RLJ, Bogers AJJC, Pieter KA. Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag. 2011;7(1):255–63.PubMedPubMedCentral Head SJ, Mostafa Mokhles M, Osnabrugge RLJ, Bogers AJJC, Pieter KA. Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag. 2011;7(1):255–63.PubMedPubMedCentral
35.
go back to reference Yun S, Ph D, Song J, Ph D. Early surgery versus conventional treatment for infective endocarditis. New Eng J Med. 2012;366(26):2466–73.CrossRef Yun S, Ph D, Song J, Ph D. Early surgery versus conventional treatment for infective endocarditis. New Eng J Med. 2012;366(26):2466–73.CrossRef
36.
go back to reference Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121(8):1005–13.CrossRef Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121(8):1005–13.CrossRef
39.
go back to reference Morita Y, Haruna T, Haruna Y, Nakane E, Yamaji Y, Hayashi H, et al. Thirty-day readmission after infective endocarditis: analysis from a nationwide readmission database. J Am Heart Assoc. 2019;8(9):e011598.CrossRef Morita Y, Haruna T, Haruna Y, Nakane E, Yamaji Y, Hayashi H, et al. Thirty-day readmission after infective endocarditis: analysis from a nationwide readmission database. J Am Heart Assoc. 2019;8(9):e011598.CrossRef
Metadata
Title
Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018
Authors
Catarina Sousa
Paulo Nogueira
Fausto J. Pinto
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01937-3

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue